Cytopoint Canine Atopic Dermatitis Immunotherapeutic Injectable is a revolutionary new treatment used to target itch at the source to assist in the relief of atopic dermatitis (eczema) signs with a single injection. It reduces biting, licking, chewing, and scratching at the skin. With this control of the source of itching, damaged skin is able to begin the healing process.
This item ships cold.

For:

Dogs

Benefits:

• It is not known to have any drug interactions, so it is considered safe for concurrent use with other commonly prescribed medications.
• It reduces biting, licking, chewing, and scratching so skin damage is able to heal.
• A single injection could last from 4 to 8 weeks.
• It is a convenient solution for itch relief.
• It is the first licensed monoclonal antibody for controlling the symptoms of atopic dermatitis (eczema) in dogs.

Manufacturer:

Zoetis

Active ingredient(s):

Contains an a mAb specifically designed to target and neutralize cytokine interleukin-31 (IL-31)

How is Cytopoint Canine Atopic Dermatitis Immunotherapeutic Injectable, 1 ml vial sold?

Sold in strengths of 10 mg, 20 mg, 30 mg, or 40 mg in 1 ml vials.

Side effects:

Undesired immune function effects and other adverse reactions could be minimized using a targeted mechanism of action.
Some potential adverse reactions may include:

• Lethargy
• Diarrhea
• Vomiting

These side effects typically resolve themselves with no requirement for treatment.

Special Precautions:

Keep out of reach of animals and children.

Storage:

Store vials upright in original packaging at 2°-8°C/36°-47°F. It should be stored in the refrigerator but do not freeze. Potency could be affected by storage at higher temperatures.Discard vials after punctured.